About Coagulation factor X
Coagulation factor X (F10) is a protein
from Homo sapiens identified by UniProt accession
P00742, 488 residues long.
MolForge cross-references it against 0 known binders and
481 disease associations.
Target properties
| Protein name | Coagulation factor X |
| UniProt accession | P00742 |
| Gene | F10 |
| Organism | Homo sapiens |
| Length | 488 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (12)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (481)
Diseases linked to this target (Open Targets).
- congenital factor X deficiency · score 0.81
- factor X deficiency · score 0.71
- venous thromboembolism · score 0.66
- deep vein thrombosis · score 0.65
- atrial fibrillation · score 0.61
- COVID-19 · score 0.58
- stroke · score 0.58
- hemophilia A · score 0.58
- pulmonary embolism · score 0.58
- acute coronary syndrome · score 0.55
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P00742-F1 | alphafold | PREDICTED | 80.23 | — |
Amino-acid sequence (488 residues)
MGRPLHLVLL SASLAGLLLL GESLFIRREQ ANNILARVTR ANSFLEEMKK GHLERECMEE TCSYEEAREV FEDSDKTNEF WNKYKDGDQC ETSPCQNQGK CKDGLGEYTC TCLEGFEGKN CELFTRKLCS LDNGDCDQFC HEEQNSVVCS CARGYTLADN GKACIPTGPY PCGKQTLERR KRSVAQATSS SGEAPDSITW KPYDAADLDP TENPFDLLDF NQTQPERGDN NLTRIVGGQE CKDGECPWQA LLINEENEGF CGGTILSEFY ILTAAHCLYQ AKRFKVRVGD RNTEQEEGGE AVHEVEVVIK HNRFTKETYD FDIAVLRLKT PITFRMNVAP ACLPERDWAE STLMTQKTGI VSGFGRTHEK GRQSTRLKML EVPYVDRNSC KLSSSFIITQ NMFCAGYDTK QEDACQGDSG GPHVTRFKDT YFVTGIVSWG EGCARKGKYG IYTKVTAFLK WIDRSMKTRG LPKAKSHAPE VITSSPLK
Explore Coagulation factor X with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets